<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-30T15:06:38Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/3818" metadataPrefix="didl">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/3818</identifier><datestamp>2024-07-18T09:40:35Z</datestamp><setSpec>com_10259_9433</setSpec><setSpec>com_10259_5087</setSpec><setSpec>com_10259_2728</setSpec><setSpec>col_10259_9434</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2015-08-27T10:35:32Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10259_3818">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10259/3818</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Determinación analítica de fármacos con propiedades antiepilépticas</dc:title>
<dc:creator>Iglesias García, Ángela</dc:creator>
<dc:contributor>Arcos Martínez, Julia</dc:contributor>
<dc:contributor>Alonso Lomillo, Mª Asunción</dc:contributor>
<dc:contributor>Universidad de Burgos. Departamento de Química</dc:contributor>
<dc:description>The necessity of disposable biosensors for simple, rapid and inexpensive&#xd;
analysis in fields such as clinical, environmental or industrial has been highlighted&#xd;
over the past decade. In this way, screen-printed electrodes (SPEs) have been shown&#xd;
as inexpensive and reproducible devices for mass production of miniaturized&#xd;
biosensors [1-4]. These transducers, building by sequential layer deposition on the&#xd;
surface of ceramic or plastic substrates and curing steps, have been conventionally&#xd;
linked to the sensing element by adsorption, cross-linking, electropolymerization or&#xd;
covalent bonding. Bioelements are commonly immobilized after the printing and&#xd;
firing processes, because of the high temperatures reached during the curing step [5].&#xd;
The immobilization procedure requires maintaining the initial properties of the&#xd;
enzyme intact. Thus, successful developments of biosensors largely rely on the cost&#xd;
and stability of the sensing elements [3].&#xd;
Even if the above-mentioned immobilization procedures are efficient, they&#xd;
imply additional steps after fabrication of the screen-printed carbon electrodes&#xd;
(SPCEs), which extends the whole biosensor manufacturing. Screen-printing&#xd;
techniques also offer another attractive immobilization procedure consisting of&#xd;
printing the biological material. Enzymes, which are proteins able to catalyse specific&#xd;
chemical reactions in vivo, are by far the most commonly employed bioelements [1].&#xd;
Enzymes can be integrated into the ink to form the sensing paste, which can be&#xd;
screen-printed resulting in biosensors fabricated by only one technology [6-8].&#xd;
Undoubtedly, this immobilization procedure, which is known as automated&#xd;
immobilization, is particularly interesting for mass production of disposable&#xd;
biosensors.&#xd;
This work presents a simple way for preparing SPCEs modified with&#xd;
Horseradish peroxidase (HRP) for the determination of Levetiracetam (LEV). This&#xd;
second-generation antiepileptic drug (AEDs) has been previously determined using a&#xd;
SPCE-biosensor based on the immobilization of Horseradish peroxidase (HRP) by&#xd;
pyrrole electropolymerization [9] and covalent bonding [10] The screen-printing of&#xd;
HRP-containing ink (SPCHRPEs) offers a higher rapidity and simplicity in the&#xd;
manufacturing process of biosensors for LEV determination.</dc:description>
<dc:date>2015-08-27T10:35:32Z</dc:date>
<dc:date>2015-08-27T10:35:32Z</dc:date>
<dc:date>2014</dc:date>
<dc:type>info:eu-repo/semantics/bachelorThesis</dc:type>
<dc:identifier>http://hdl.handle.net/10259/3818</dc:identifier>
<dc:language>spa</dc:language>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>Este documento está sujeto a una licencia de uso Creative Commons, por la cual está permitido hacer copia, distribuir y comunicar públicamente la obra siempre que se cite al autor original y no se haga de él uso comercial ni obra derivada</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10259_3818_1">
<d:Resource ref="https://riubu.ubu.es/bitstream/10259/3818/1/Iglesias_Garc%c3%ada.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>